Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127427661 | 12742766 | 1 | I | 201508 | 20160908 | 20160914 | 20160914 | EXP | US-REGENERON PHARMACEUTICALS, INC.-2016-21460 | REGENERON | 0.00 | Y | 0.00000 | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127427661 | 12742766 | 1 | PS | EYLEA | AFLIBERCEPT | 1 | Intraocular | UNK | U | U | 125387 | INJECTION | |||||||
| 127427661 | 12742766 | 2 | SS | EYLEA | AFLIBERCEPT | 1 | Intraocular | BOTH EYES (OU) | U | U | 125387 | INJECTION | |||||||
| 127427661 | 12742766 | 3 | SS | EYLEA | AFLIBERCEPT | 1 | Intraocular | OU | U | U | 125387 | INJECTION | |||||||
| 127427661 | 12742766 | 4 | SS | EYLEA | AFLIBERCEPT | 1 | Intraocular | OU | U | U | 125387 | INJECTION | |||||||
| 127427661 | 12742766 | 5 | SS | EYLEA | AFLIBERCEPT | 1 | Intraocular | OU | U | U | 125387 | INJECTION | |||||||
| 127427661 | 12742766 | 6 | SS | LUCENTIS | RANIBIZUMAB | 1 | Intraocular | BOTH EYES EVERY OTHER MONTH | U | U | 0 | ||||||||
| 127427661 | 12742766 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127427661 | 12742766 | 8 | C | GLIPIZIDE. | GLIPIZIDE | 1 | U | 0 | |||||||||||
| 127427661 | 12742766 | 9 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 0 | |||||||||||
| 127427661 | 12742766 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | U | 0 | |||||||||||
| 127427661 | 12742766 | 11 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | U | 0 | |||||||||||
| 127427661 | 12742766 | 12 | C | LUTEIN /01638501/ | LUTEIN | 1 | U | 0 | |||||||||||
| 127427661 | 12742766 | 13 | C | MULTIVITAMIN /00097801/ | VITAMINS | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127427661 | 12742766 | 1 | Product used for unknown indication |
| 127427661 | 12742766 | 6 | Product used for unknown indication |
| 127427661 | 12742766 | 7 | Product used for unknown indication |
| 127427661 | 12742766 | 8 | Product used for unknown indication |
| 127427661 | 12742766 | 9 | Product used for unknown indication |
| 127427661 | 12742766 | 10 | Product used for unknown indication |
| 127427661 | 12742766 | 11 | Product used for unknown indication |
| 127427661 | 12742766 | 12 | Product used for unknown indication |
| 127427661 | 12742766 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127427661 | 12742766 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127427661 | 12742766 | Cerebrovascular accident | |
| 127427661 | 12742766 | Oral surgery |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127427661 | 12742766 | 1 | 2015 | 0 | ||
| 127427661 | 12742766 | 2 | 201504 | 0 | ||
| 127427661 | 12742766 | 3 | 201508 | 0 | ||
| 127427661 | 12742766 | 4 | 201601 | 0 | ||
| 127427661 | 12742766 | 5 | 20160427 | 0 | ||
| 127427661 | 12742766 | 6 | 2014 | 0 |